Detalhe da pesquisa
1.
Intermittent fasting in the prevention and treatment of cancer.
CA Cancer J Clin
; 71(6): 527-546, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383300
2.
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Breast Cancer Res
; 25(1): 112, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37784176
3.
Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA).
Breast Cancer Res Treat
; 185(3): 639-646, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219484
4.
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer.
Breast Cancer Res Treat
; 189(1): 187-202, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173924
5.
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021.
J Natl Compr Canc Netw
; 19(9): 1006-1019, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551388
6.
Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only Metastases.
Oncologist
; 23(11): 1282-1288, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30120166
7.
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Breast Cancer Res Treat
; 170(1): 101-109, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470805
8.
Inadequate and delayed characterization of cutaneous reactions for US Food and Drug Administration-approved oncologic drugs from 2011-2020 leading to medication discontinuation.
J Am Acad Dermatol
; 85(5): 1351-1352, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236990
9.
Severe hyponatremia following cyclophosphamide infusion in breast cancer patients.
Breast J
; 24(4): 691-692, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29498456
10.
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).
NPJ Breast Cancer
; 9(1): 1, 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609389
11.
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis.
JCO Precis Oncol
; 7: e2200531, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37141549
12.
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.
Clin Cancer Res
; 29(9): 1719-1729, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693175
13.
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer.
Clin Cancer Res
; 29(16): 3092-3100, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37265453
14.
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab.
Breast Cancer (Dove Med Press)
; 14: 113-123, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35515356
15.
Loneliness, social isolation, and social support in older adults with active cancer during the COVID-19 pandemic.
J Geriatr Oncol
; 13(8): 1122-1131, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041993
16.
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis.
NPJ Breast Cancer
; 8(1): 35, 2022 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314693
17.
Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer.
EBioMedicine
; 86: 104316, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332363
18.
Single-Institution Phase 1/2 Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial-Breast Irradiation for Hormone Sensitive Stage 0-I Breast Cancer.
Int J Radiat Oncol Biol Phys
; 107(2): 344-352, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32084524
19.
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-33015522
20.
Characterization of bone only metastasis patients with respect to tumor subtypes.
NPJ Breast Cancer
; 4: 2, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29387785